लोड हो रहा है...
Glutaminase inhibition improves FLT3 inhibitor therapy for acute myeloid leukemia
Acute myeloid leukemia (AML) is a blood cancer that is poorly responsive to conventional cytotoxic chemotherapy and a diagnosis of AML is usually fatal. More effective and better-tolerated therapies for AML are desperately needed. Activating mutations in FMS-like tyrosine kinase 3 (FLT3) are one of...
में बचाया:
| में प्रकाशित: | Exp Hematol |
|---|---|
| मुख्य लेखकों: | , , , , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
2017
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5815916/ https://ncbi.nlm.nih.gov/pubmed/28947392 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.exphem.2017.09.007 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|